Ati cautat: studiile clinice
Protocol terapeutic: B01AX07 – DCI CAPLACIZUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AA25-SHUa – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L04AA25-HPN – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L01EK03 – DCI TIVOZANIBUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: A16AX08 – DCI TEDUGLUTIDUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: N07XX11 – DCI PITOLISANTUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: B02BX06 – DCI EMICIZUMAB (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: A10BD24 – DCI COMBINAČšII ERTUGLIFLOZINUM + SITAGLIPTINUM (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: M09AX10 – DCI RISDIPLAMUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
EMA: Vaccinurile care ofera protectie impotriva variantei Omicron pot fi utilizate ca rapel